Cezarox® Epi

Цезарокс® Эпи

About the product

Trade name: Cezarox® Epi

Dosage form: capsules

Ingredients: each capsule contains active ingredients: diindolylmethane – 100 mg; fish liver oil* – 20 mg; excipients: polysorbate 80 – 430 mg; excipients for banding: gelatin – 20 mg, polysorbate 80 – 0.4 mg; natural colorant – copper complexes of chlorophylls (E141) – 1.5 mg. Capsule composition: body – gelatin 100%; cap – gelatin 100% (manufacturer’s specification). *Fatty oil obtained from the fresh liver of Atlantic cod (Gadus morhua) and other species of the cod family (Gadidae)

For the patient

Medication for the treatment of respiratory diseases

Indications for use:

As part of combination therapy for viral pneumonia caused by the novel coronavirus infection (COVID-19) of moderate to severe severity in patients over 18 years of age

Contraindications:

  • Hypersensitivity to the active substance or any other component of the product
  • Pregnancy
  • Breastfeeding
  • Children under the age of 18

Contact us

Select a service*

Pharmacovigilance

MiraxBioPharma is committed to ensuring the quality and safety of its products and pays special attention to collecting and analyzing information about adverse reactions and complaints associated with the use of our products.

If you become aware of any adverse reactions to the medicinal product Cezarox® Epi or of a lack of therapeutic effect, please report it via email at: adversareaction@drugsafety.ru or by phone: +7 (800) 777-86-04.

If you become aware of any adverse reactions to other MiraxBioPharma medicinal products or of a lack of therapeutic effect, please report it via email at: GVP@mbpharma.ru, by phone: +7 (495) 183-38-41 or by filling out the electronic form below

Adverse reaction reporting form
Specify gender*
Suspected medicinal product information
Reporter information

Preferred method of contact*
We use cookies

By using this website, you consent to the collection and processing of your personal data, including through third-party services, and the use of cookies and web analytics tools, under the terms outlined in the Personal Data Processing Policy.